Psychotic depression: a peculiar presentation for multiple sclerosis.
Multiple sclerosis (MS) is frequently associated with a number of different psychiatric syndromes. Solely psychiatric syndrome may be the first clinical presentation of multiple sclerosis. We report a patient whose first attack was psychotic depression. The present case emphasizes that psychiatric symptoms can occur at any time during the course of the disease and, moreover, may be the presenting feature.
Agan
Kadriye
K
Department of Neurology, Faculty of Medicine, Marmara University, Istanbul, Turkey. kadiagan@yahoo.com
Gunal
Dilek Ince
DI
Afsar
Nazire
N
Tuncer
Nese
N
Kuscu
Kemal
K
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000328:Adult; D000341:Affective Disorders, Psychotic / Q000209:etiology / Q000473:pathology* / Q000503:physiopathology; D000928:Antidepressive Agents / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001921:Brain / Q000473:pathology* / Q000503:physiopathology; D003866:Depressive Disorder / Q000209:etiology / Q000473:pathology* / Q000503:physiopathology; D003937:Diagnosis, Differential; D003951:Diagnostic Errors; D018450:Disease Progression; D005260:Female; D006801:Humans; D000068556:Interferon beta-1a; D016899:Interferon-beta / Q000627:therapeutic use; D008279:Magnetic Resonance Imaging; D009103:Multiple Sclerosis / Q000150:complications / Q000473:pathology* / Q000523:psychology; D043025:Oligoclonal Bands / Q000134:cerebrospinal fluid; D009902:Optic Neuritis / Q000209:etiology; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use; D017211:Treatment Failure; D016896:Treatment Outcome
D000276:Adjuvants, Immunologic; D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D000068556:Interferon beta-1a; D016899:Interferon-beta; D043025:Oligoclonal Bands; D017367:Selective Serotonin Reuptake Inhibitors